Oral and Maxillofacial Surgery

Association between gene polymorphisms with oral squamous cell carcinoma risk and survival in multiple ethnicities: a systematic review

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Association between gene polymorphisms with oral squamous cell carcinoma risk and survival in multiple ethnicities: a systematic review

Background: There are more than 30 genes polymorphisms associated with risk and survival rate of oral squamous cell carcinoma (OSCC). Nevertheless, different ethnicity could show different genotype and allele as…

read more

Gemcitabine induces phenotypic alterations of tumor cells that facilitate antitumor T cell responses in a mouse model of oral cancer

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Gemcitabine induces phenotypic alterations of tumor cells that facilitate antitumor T cell responses in a mouse model of oral cancer

Background and objectives: Gemcitabine (GEM) is a pyrimidine nucleoside analogue that is a new chemotherapeutic agent used for treating various cancers. Because accumulating evidence indicates that GEM may activate host…

read more

Discrepancy between clinical and pathological staging of head and neck cancer – ‘the stage migration’

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Discrepancy between clinical and pathological staging of head and neck cancer – ‘the stage migration’

Rationale: The TNM system for classification of Head and neck malignant tumours is a universally accepted, widely used, staging method which helps clinicians and researchers to choose from treatment options,…

read more

Continued monitoring of salivary interleukin-6 levels may predict early and late locoregional recurrence in patients with oral squamous cell carcinoma

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Continued monitoring of salivary interleukin-6 levels may predict early and late locoregional recurrence in patients with oral squamous cell carcinoma

Background and objective: We have already demonstrated that post-operative concentration of salivary interleukin-6 (IL-6) may predict early locoregional recurrence in oral squamous cell carcinoma (OSCC) (Head & Neck; 2012). This…

read more
Get VIDEdental app for watching clinical videos